SG152257A1 - Topical preparation containing ambroxol - Google Patents

Topical preparation containing ambroxol

Info

Publication number
SG152257A1
SG152257A1 SG200902737-6A SG2009027376A SG152257A1 SG 152257 A1 SG152257 A1 SG 152257A1 SG 2009027376 A SG2009027376 A SG 2009027376A SG 152257 A1 SG152257 A1 SG 152257A1
Authority
SG
Singapore
Prior art keywords
preparation containing
topical preparation
containing ambroxol
ambroxol
application
Prior art date
Application number
SG200902737-6A
Other languages
English (en)
Inventor
Anke Esperester
Frieder Ulrich Maerz
Claudia Mueller
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966914&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG152257(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of SG152257A1 publication Critical patent/SG152257A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG200902737-6A 2004-05-03 2005-04-22 Topical preparation containing ambroxol SG152257A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004021992A DE102004021992A1 (de) 2004-05-03 2004-05-03 Topische Zubereitung enthaltend Ambroxol

Publications (1)

Publication Number Publication Date
SG152257A1 true SG152257A1 (en) 2009-05-29

Family

ID=34966914

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200902737-6A SG152257A1 (en) 2004-05-03 2005-04-22 Topical preparation containing ambroxol

Country Status (21)

Country Link
US (1) US20050266058A1 (ja)
EP (1) EP1744738A1 (ja)
JP (1) JP2007536296A (ja)
KR (1) KR20070005020A (ja)
CN (1) CN1950076A (ja)
AR (1) AR049036A1 (ja)
AU (1) AU2005239809A1 (ja)
BR (1) BRPI0510600A (ja)
CA (1) CA2565183A1 (ja)
DE (1) DE102004021992A1 (ja)
EC (1) ECSP066970A (ja)
IL (1) IL178975A0 (ja)
MD (1) MD4093B1 (ja)
MX (1) MXPA06012655A (ja)
PE (1) PE20060214A1 (ja)
RU (1) RU2381794C2 (ja)
SG (1) SG152257A1 (ja)
TW (1) TW200603787A (ja)
UA (1) UA87841C2 (ja)
WO (1) WO2005107732A1 (ja)
ZA (1) ZA200608017B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012003276A (es) * 2009-09-18 2012-04-19 Procter & Gamble Sustrato que comprende una composicion de locion que limita la adherencia de material fecal o flujo menstrual a la piel.
US20130287714A1 (en) * 2010-11-12 2013-10-31 Sven Gohla Cosmetic and/or dermatological preparations containing snow algae extract
BR112013012815A2 (pt) * 2010-12-23 2016-09-13 Lectio Pharmaentwicklungs Und Verwertungs Gmbh solução aquosa de ambroxol
EP2685960B1 (de) * 2011-03-14 2018-12-19 Sanofi-Aventis Deutschland GmbH Verwendung einer sprühfähigen zusammensetzung enthaltend ambroxol
EA027817B1 (ru) * 2011-03-21 2017-09-29 Бёрингер Ингельхайм Интернациональ Гмбх Лекарственная форма, содержащая твёрдую амброксолсодержащую композицию, и ее применение
RU2513514C1 (ru) * 2012-11-23 2014-04-20 Общество с ограниченной ответственностью "НПК "Трифарма" Фармацевтическая композиция, содержащая налбуфина гидрохлорид, ее применение для лечения болевого синдрома средней и высокой интенсивности и способ получения фармацевтической композиции
WO2015125757A1 (ja) * 2014-02-18 2015-08-27 大正製薬株式会社 内服液剤
KR102447263B1 (ko) * 2014-05-23 2022-09-26 사노피-아벤티스 도이칠란트 게엠베하 암브록솔 하이드로클로라이드를 함유하는 기침 약물
WO2018089797A1 (en) 2016-11-14 2018-05-17 Mingwu Wang Formulations for the treatment of ocular surface diseases and related methods
EP3654960A1 (en) 2017-07-16 2020-05-27 Neuere, LLC Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity
JP7077582B2 (ja) * 2017-11-13 2022-05-31 京セラドキュメントソリューションズ株式会社 現像剤補給装置およびそれを備えた画像形成装置
CA3087079A1 (en) 2018-01-26 2019-08-01 Neuere, Llc Use of ambroxol to improve skin barrier function
WO2020030991A1 (en) * 2018-08-09 2020-02-13 Nal Pharmaceutical Group Limited Dosage form for insertion into the mouth
CN113995721A (zh) * 2020-07-27 2022-02-01 德国吉麦医疗技术有限公司 一种盐酸氨溴索口腔喷雾溶液及其制备方法
CN112168783A (zh) * 2020-10-26 2021-01-05 山东裕欣药业有限公司 一种呼吸系统药物口服喷雾剂及制备方法
CN112168782A (zh) * 2020-10-26 2021-01-05 山东裕欣药业有限公司 一种呼吸系统药物口服喷雾剂的制备方法
CN118021768A (zh) * 2022-11-14 2024-05-14 上海云晟研新生物科技有限公司 氨溴索口溶膜组合物、其制备方法及应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
DE3317530A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antischnarchmittel
DE3610997A1 (de) * 1986-04-02 1987-10-15 Krewel Werke Gmbh Ambroxol-nasenspray
IT1252185B (it) * 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
KR930011993B1 (ko) * 1991-12-23 1993-12-23 주식회사 럭키 지속성-방출형 약학적 조성물 및 그 제조방법
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
US5972326A (en) * 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
JPH10259130A (ja) * 1997-01-17 1998-09-29 Taisho Pharmaceut Co Ltd 経口投与用製剤
JP4983750B2 (ja) * 1997-01-17 2012-07-25 大正製薬株式会社 経口投与用製剤
JP2000007561A (ja) * 1998-06-18 2000-01-11 Nissho Corp 塩酸アンブロキソール水溶液製剤
EP1140021B1 (en) * 1998-12-23 2004-08-04 Idea Ag Improved formulation for topical non-invasive application in vivo
DE19933148A1 (de) * 1999-07-20 2001-01-25 Boehringer Ingelheim Int Ambroxolhaltige Lutschtablette
US20030216423A1 (en) * 2000-05-24 2003-11-20 Sergio Ulloa Stable liquid and solid formulations
KR20030045473A (ko) * 2001-12-04 2003-06-11 대신제약주식회사 점막부착성을 가지는 의약품 조성물
JP2009235093A (ja) * 2001-12-21 2009-10-15 Daiichi Sankyo Healthcare Co Ltd 鼻炎用医薬組成物
US20030171391A1 (en) * 2002-01-25 2003-09-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of chronic pain
DE10203104A1 (de) * 2002-01-25 2003-08-07 Boehringer Ingelheim Pharma Ambroxol für die Behandlung chronischer Schmerzen
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
DE10208313A1 (de) * 2002-02-27 2003-09-11 Boehringer Ingelheim Pharma Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
DE10332473A1 (de) * 2003-07-16 2005-02-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung von Epilepsie
DE10332486A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
DE10332487A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen
CN1546008A (zh) * 2003-12-02 2004-11-17 沈阳药科大学 盐酸氨溴索液体缓释制剂及其制备方法
CN1628645A (zh) * 2003-12-15 2005-06-22 南京金鹰医药科技开发有限公司 盐酸氨溴索口腔崩解片及其制备方法
CN1602848A (zh) * 2004-08-23 2005-04-06 南昌弘益科技有限公司 盐酸氨索溴滴丸及其制备方法
CN1299673C (zh) * 2004-10-01 2007-02-14 耿燕 盐酸氨溴索滴丸及其制备方法
CN1650868A (zh) * 2004-12-02 2005-08-10 四川川投医药生物技术有限责任公司 一种治疗肺部感染性疾病的复方药物制剂及其制备方法
CN1839802A (zh) * 2006-01-27 2006-10-04 无锡山禾药业股份有限公司 一种盐酸氨溴索口腔崩解片及其制备方法
CN1820755A (zh) * 2006-04-03 2006-08-23 陈旭良 头孢呋辛/盐酸氨溴索的药物组合
CN1843372A (zh) * 2006-05-11 2006-10-11 陈旭良 氨溴索与两种抗菌药物分别组成的药物组合
CN101099730A (zh) * 2006-07-03 2008-01-09 天津康鸿医药科技发展有限公司 含盐酸氨溴索与愈创木酚甘油醚活性成分的口服固体制剂
CN101084912A (zh) * 2007-07-02 2007-12-12 山东省医药工业研究所 复方盐酸氨溴索缓释片及其制备方法
JP5337405B2 (ja) * 2007-09-17 2013-11-06 ザ・ホスピタル・フォー・シック・チルドレン ゴーシェ病の治療方法
CN101480382A (zh) * 2008-01-09 2009-07-15 大百汇生物科技（深圳）有限公司 一种治疗急慢性鼻窦炎的药物组合物及其制备方法
CN101352417A (zh) * 2008-08-29 2009-01-28 扬州市三药制药有限公司 盐酸氨溴索口服溶液及其制备方法
CN101590043A (zh) * 2009-07-03 2009-12-02 北京华禧联合科技发展有限公司 一种治疗呼吸道感染的复方制剂及其制备方法

Also Published As

Publication number Publication date
US20050266058A1 (en) 2005-12-01
UA87841C2 (ru) 2009-08-25
DE102004021992A1 (de) 2005-11-24
ZA200608017B (en) 2008-07-30
MXPA06012655A (es) 2007-01-16
ECSP066970A (es) 2006-12-29
CN1950076A (zh) 2007-04-18
BRPI0510600A (pt) 2007-10-30
JP2007536296A (ja) 2007-12-13
MD4093B1 (ro) 2011-02-28
AR049036A1 (es) 2006-06-21
RU2006142735A (ru) 2008-06-20
TW200603787A (en) 2006-02-01
EP1744738A1 (de) 2007-01-24
AU2005239809A1 (en) 2005-11-17
PE20060214A1 (es) 2006-04-26
WO2005107732A1 (de) 2005-11-17
RU2381794C2 (ru) 2010-02-20
KR20070005020A (ko) 2007-01-09
CA2565183A1 (en) 2005-11-17
IL178975A0 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
SG152257A1 (en) Topical preparation containing ambroxol
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
NO20043367L (no) Oralt farmasoytisk preparat
NO20041070L (no) Preparat for behandling av vanlig forkjolelse.
ES2187300A1 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
SE0401342D0 (sv) Therapeutic compounds
RS52457B (en) POWDER FORMULATION FOR VALGANCICLOVIR
AR054806A1 (es) Formulaciones de estrogenos conjugados y bazedoxifeno
SE0402762D0 (sv) Indazole sulphonamide derivatives
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
ATE505203T1 (de) Pharmazeutische kombination aus aliskiren und valsartan
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
WO2006076097A3 (en) Stable non-crystalline formulation comprising losartan
ATE501719T1 (de) Methoden und zusammensetzungen zur beruhigung von mund- und nasenschleimhäuten
DE602006012962D1 (de) Pharmazeutische Zubereitungen von Ciprofloxacin
SE0000303D0 (sv) Novel compounds
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
DE50005714D1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl